Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus Optimal Parameters for Prediction of Heart Failure

被引:57
|
作者
Wang, Ying [1 ]
Yang, Hong [1 ]
Quan Huynh [1 ,2 ]
Nolan, Mark [1 ]
Negishi, Kazuaki [1 ]
Marwick, Thomas H. [1 ,2 ]
机构
[1] Menzies Inst Med Res, Hobart, Tas, Australia
[2] Baker Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia
关键词
community; echocardiography; global longitudinal strain; stage B heart failure; subclinical LV dysfunction; T2DM; LEFT-VENTRICULAR HYPERTROPHY; GLOBAL LONGITUDINAL STRAIN; SYSTOLIC DYSFUNCTION; PROGNOSTIC VALUE; LV DYSFUNCTION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; CARDIOMYOPATHY; ASSOCIATION; PREVALENCE;
D O I
10.1016/j.jcmg.2018.03.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to identify whether impaired global longitudinal strain (GLS), diastolic dysfunction (DD), or left atrial enlargement (LAE) should be added to stage B heart failure (SBHF) criteria in asymptomatic patients with type 2 diabetes mellitus. BACKGROUND SBHF is a precursor to clinical heart failure (HF), and its recognition justifies initiation of cardioprotective therapy. However, original definitions of SBHF were based on LV hypertrophy and impaired ejection fraction. METHODS Patients with asymptomatic type 2 diabetes mellitus >= 65 years of age (age 71 +/- 4 years; 55% men) with preserved ejection fraction and no ischemic heart disease were recruited from a community-based population. All underwent a standard clinical evaluation, and a comprehensive echocardiogram, including assessment of left ventricular hypertrophy (LVH), LAE, DD (abnormal E/e'), and GLS (<16%). Over a median follow-up of 1.5 years (range 0.5 to 3), 20 patients were lost to follow-up, and 290 individuals were entered into the final analyses. RESULTS In this asymptomatic group, LV dysfunction was identified in 30 (10%) by DD, 68 (23%) by LVH, 102 (35%) by LAE, and 68 (23%) by impaired GLS. New-onset HF developed in 45 patients and 4 died, giving an event rate of 112/1,000 person-years. Survival free of the composite endpoint (HF and death) was about 1.5-ford higher in patients without a normal, compared with an abnormal echocardiogram. LVH, LAE, and GLS <16% were associated with increased risk of the composite endpoint, independent of ARIC risk score and glycosytated hemoglobin, but abnormal E/e' was not. The addition of left atrial volume and GLS provided incremental value to the current standard of clinical risk (ARIC score) and LVH. In a competing-risks regression analysis, LVH (hazard ratio: 2.90; p < 0.001) and GLS <16% (hazard ratio: 2.26; p = 0.008), but not DD and LAE were associated with incident HF. CONCLUSIONS Subclinical left ventricular systolic dysfunction is prevalent in asymptomatic elderly patients with type 2 diabetes mellitus, and impaired GLS is independent and incremental to LVH in the prediction of incident HF. (C) 2018 by the American College of Cardiology Foundation.
引用
收藏
页码:1390 / 1400
页数:11
相关论文
共 50 条
  • [1] Nonischemic heart failure in diabetes mellitus
    Guha, Ashrith
    Harmancey, Romain
    Taegtmeyer, Heinrich
    [J]. CURRENT OPINION IN CARDIOLOGY, 2008, 23 (03) : 241 - 248
  • [2] Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure
    Johansson, Isabelle
    Dahlstrom, Ulf
    Edner, Magnus
    Nasman, Per
    Ryden, Lars
    Norhammar, Anna
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (13) : 1404 - 1416
  • [3] Type 2 diabetes mellitus in patients with terminal stage heart failure
    Doka, G.
    Mlynarova, J.
    Krenek, P.
    Musil, P.
    Klimas, J.
    Goncalvesova, E.
    Kyselovic, J.
    [J]. DIABETOLOGIA, 2014, 57 : S504 - S504
  • [4] Type 2 diabetes mellitus and heart failure
    Choy, Christine K.
    Rodgers, Jo E.
    Nappi, Jean M.
    Haines, Stuart T.
    [J]. PHARMACOTHERAPY, 2008, 28 (02): : 170 - 192
  • [5] Stage B predictors of non-ischemic heart failure in type 2 diabetes mellitus
    Klabnik, A.
    Murin, J.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1591 - 1591
  • [6] Diabetes mellitus and Heart Failure - deadly duo Diabetes mellitus Type 2 and Heart Failure affect each other
    Stratmann, B.
    Lee-Barkey, Y. H.
    Tschoepe, D.
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (04): : 205 - 212
  • [7] Sotagliflozin for Type 2 Diabetes mellitus and Heart Failure
    Pavlicek, Vojtech
    [J]. DIABETOLOGE, 2021, 17 (02): : 216 - 217
  • [8] Heart failure and development of type 2 diabetes mellitus
    Antonia Flores-Le-Roux, Juana
    Benaiges Boix, David
    Pedro-Botet, Juan
    [J]. MEDICINA CLINICA, 2012, 138 (13): : 579 - 583
  • [9] Heart failure in patients with type 2 diabetes mellitus
    Vlad, Adrian
    Serban, Viorel
    Timar, Romulus
    Darabantiu, Dan
    [J]. DIABETES, 2007, 56 : A588 - A588
  • [10] A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus
    Williams, Brent A.
    Geba, Daniela
    Cordova, Jeanine M.
    Shetty, Sharash S.
    [J]. CLINICAL CARDIOLOGY, 2020, 43 (03) : 275 - 283